Disrupted-In-Schizophrenia-1 (DISC1) interactome and mental disorders: Impact of mouse models

Neuroscience and Biobehavioral Reviews

Volumn 45, Issue , 2014, Pages 271-294

  Lipina, Tatiana V ^a   Roder, John C ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Behavioural phenotype; DISC1 interactome; Genetic mouse models; Mental diseases network

Indexed keywords

DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; KINESIN; MOLECULAR MOTOR; CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; PHOSPHODIESTERASE IV; WNT PROTEIN; DISC1 PROTEIN, HUMAN; DISC1 PROTEIN, MOUSE; NERVE PROTEIN;

CELL FUNCTION; DISC1 GENE; DISEASE PREDISPOSITION; GENE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC LINE; GENETIC RISK; INTRACELLULAR TRANSPORT; MENTAL DISEASE; MOUSE; MOUSE MODEL; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; BEHAVIOR ASSESSMENT; BRAIN MAPPING; BRAIN MITOCHONDRION; BRAIN NUCLEUS; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSPORT; CENTROSOME; CHROMOSOME TRANSLOCATION; DISEASE MODEL; GENE DISRUPTION; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC MODEL; HUMAN; INTRACELLULAR SIGNALING; MENTAL FUNCTION ASSESSMENT; MOLECULAR PATHOLOGY; NERVE CELL DIFFERENTIATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; GENETICS; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MENTAL DISORDERS; MICE; NERVE TISSUE PROTEINS;

EID: 84904563247     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2014.07.001     Document Type: Review

References (301)

1. Abazyan B., Nomura J., Kannan G., Ishizuka K., Tamashiro K.L., Nucifora F., Pogorelov V., Ladenheim B., Yang C., Krasnova I.N., Cadet J.L., Pardo C., Mori S., Kamiya A., Vogel M.W., Sawa A., Ross C.A., Pletnikov M.V. Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology. Biol. Psychiatry 2010, 68:1172-1181.
2. Abazyan B., Dziedzic J., Hua K., Abazyan S., Yang C., Mori S., Pletnikov M.V., Guilarte T.R. Chronic exposure of mutant DISC1 mice to lead produces sex-dependent abnormalities consistent with schizophrenia and related mental disorders: a gene-environment interaction study. Schizophr. Bull. 2013, (June). (Epub ahead of print).
3. Alessandri S.M. Attention, play, and social behavior in ADHD preschoolers. J. Abnorm. Child Psychol. 1992, 20:289-302.
4. Amberger J., Bocchini C.A., Scott A.F., Hamosh A. McKusick's online mendelian inheritance in man (OMIM). Nucleic Acids Res. 2009, 37:D793-D796.
5. Ameri K., Harris A.L. Activating transcription factor 4. Int. J. Biochem. Cell Biol. 2008, 40:14-21.
6. An J., Shi J., He Q., Lui K., Liu Y., Huang Y., Sheikh M.S. CHCM1/CHCHD6, novel mitochondrial protein linked to regulation of mitofilin and mitochondrial cristae morphology. J. Biol. Chem. 2012, 287:7411-7426.
7. Anderson P. Assessment and development of executive function (EF) during childhood. Child Neuropsychol. 2003, 8:71-82.
8. Arguello P.A., Gogos J.A. Modeling madness in mice: one piece at a time. Neuron 2006, 52:179-196.
9. Ayalew M., Le-Niculescu H., Levey D.F., Jain N., Changala B., Patel S.D., Winiger E., Breier A., Shekhar A., Amdur R., Koller D., Nurnberger J.I., Corvin A., Geyer M., Tsuang M.T., Salomon D., Schork N.J., Fanous A.H., O'Donovan M.C., Niculescu A.B. Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol. Psychiatry 2012, 17:887-905.
10. Ayhan Y., Abazyan B., Nomura J., Kim R., Ladenheim B., Krasnova I.N., Sawa A., Margolis R.L., Cadet J.L., Mori S., Vogel M.W., Ross C.A., Pletnikov M.V. Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Mol. Psychiatry 2011, 16:293-306.
11. Barabási A.L., Gulbahce N., Loscalzo J. Network medicine: a network-based approach to human disease. Nat. Rev. Genet. 2011, 12:56-68.
12. Barch D.M. The cognitive neuroscience of schizophrenia. Annu. Rev. Clin. Psychol. 2005, 1:321-353.
13. Bardo M., Bevins R. Conditioned place preference: what does it add to our preclinical understanding of drug reward?. Psychopharmacology 2000, 153:31-43.
14. Basu A.C., Tsai G.E., Ma C.L., Ehmsen J.T., Mustafa A.K., Han L., Jiang Z.I., Benneyworth M.A., Froimowitz M.P., Lange N., Snyder S.H., Bergeron R., Coyle J.T. Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior. Mol. Psychiatry 2009, 14:719-727.
15. Bauman M.D., Iosif A.M., Smith S.E., Bregere C., Amaral D.G., Patterson P.H. Activation of the maternal immune system during pregnancy alters behavioral development of rhesus monkey offspring. Biol. Psychiatry 2014, 75:332-341.
16. Beaulieu J.M., Sotnikova T.D., Yao W.D., Kockeritz L., Woodgett J.R., Gainetdinov R.R., Caron M.G. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:5099-5104.
17. Beaulieu J.M., Zhang X., Rodriguiz R.M., Sotnikova T.D., Cools M.J., Wetsel W.C., Gainetdinov R.R., Caron M.G. Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:1333-1338.
18. Beaulieu J.M. A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health. J. Psychiatry Neurosci. 2012, 37:7-16.
19. Ben Abdallah N.M., Fuss J., Trusel M., Galsworthy M.J., Bobsin K., Colacicco G., Deacon R.M., Riva M.A., Kellendonk C., Sprengel R., Lipp H.P., Gass P. The puzzle box as a simple and efficient behavioral test for exploring impairments of general cognition and executive functions in mouse models of schizophrenia. Exp. Neurol. 2011, 227:42-52.
20. Beurel E. Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases. Front. Mol. Neurosci. 2011, 4:18.
21. Bhardwaj S.K., Baharnoori M., Sharif-Askari B., Kamath A., Williams S., Srivastava L.K. Behavioral characterization of dysbindin-1 deficient sandymice. Behav. Brain Res. 2009, 197:435-441.
22. Birmingham A., Anderson E., Reynolds A., Ilsley-Tyree D., Leake D., Fedorov Y., Baskerville S., Maksimova E., Robinson K., Karpilow J., Marshall W., Khvorova A. 3' UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat. Methods 2006, 3:199-204.
23. Blackwood D.H., Fordyce A., Walker M.T., St Clair D.M., Porteous D.J., Muir W.J. Schizophrenia and affective disorders - cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am. J. Hum. Genet. 2001, 69:428-433.
24. Bollen B., Matrot B., Ramanantsoa N., Van den Bergh O., D'Hooge R., Gallego J. Olfactory classical conditioning in neonatal mouse pups using thermal stimuli. Behav. Brain Res. 2012, 229:250-256.
25. Boxall R., Porteous D.J., Thomson P.A. DISC1 and Huntington's disease - overlapping pathways of vulnerability to neurological disorder?. PLOS ONE 2011, 6:e16263.
26. Bradley C.A., Peineau S., Taghibiglou C., Nicolas C.S., Whitcomb D.J., Bortolotto Z.A., Kaang B.K., Cho K., Wang Y.T., Collingridge G.L. A pivotal role of GSK-3 in synaptic plasticity. Front. Mol. Neurosci. 2012, 5:13.
27. Bradshaw N.J., Ogawa F., Antolin-Fontes B., Chubb J.E., Carlyle B.C., Christie S., Claessens A., Porteous D.J., Millar J.K. DISC1, PDE4B, and NDE1 at the centrosome and synapse. Biochem. Biophys. Res. Commun. 2008, 377:1091-1096.
28. Bradshaw N.J., Soares D.C., Carlyle B.C., Ogawa F., Davidson-Smith H., Christie S., Mackie S., Thomson P.A., Porteous D.J., Millar J.K. PKA phosphorylation of NDE1 is DISC1/PDE4 dependent and modulates its interaction with LIS1 and NDEL1. J. Neurosci. 2011, 31:9043-9054.
29. Bradshaw N.J., Porteous D.J. DISC1-binding proteins in neural development, signalling and schizophrenia. Neuropharmacology 2012, 62:1230-1241.
30. Brandon N.J., Handford E.J., Schurov I., Rain J.C., Pelling M., Duran-Jimeniz B., Camargo L.M., Oliver K.R., Beher D., Shearman M.S., Whiting P.J. Disrupted in Schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: implications for schizophrenia and other major neurological disorders. Mol. Cell Neurosci. 2004, 25:42-55.
31. Brandon N.J., Sawa A. Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat. Rev. Neurosci. 2011, 12:707-722.
32. Brown A.S., Begg M.D., Gravenstein S., Schaefer C.A., Wyatt R.J., Bresnahan M., Babulas V.P., Susser E.S. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch. Gen. Psychiatry 2004, 61:774-780.
33. Bublak P., Redel P., Finke K. Spatial and non-spatial attention deficits in neurodegenerative diseases: assessment based on Bundesen's theory of visual attention (TVA). Restor. Neurol. Neurosci. 2006, 24:287-301.
34. Burdick K.E., Kamiya A., Hodgkinson C.A., Lencz T., DeRosse P., Ishizuka K., Elashvili S., Arai H., Goldman D., Sawa A., Malhotra A.K. Elucidating the relationship between DISC1, NDEL1 and NDE1 and the risk for schizophrenia: evidence of epistasis and competitive binding. Hum. Mol. Genet. 2008, 17:2462-2473.
35. Cahill M.E., Xie Z., Day M., Photowala H., Barbolina M.V., Miller C.A., Weiss C., Radulovic J., Sweatt J.D., Disterhoft J.F., Surmeier D.J., Penzes P. Kalirin regulates cortical spine morphogenesis and disease-related behavioral phenotypes. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:13058-13063.
36. Callicott J.H., Straub R.E., Pezawas L., Egan M.F., Mattay V.S., Hariri A.R., Verchinski B.A., Meyer-Lindenberg A., Balkissoon R., Kolachana B., Goldberg T.E., Weinberger D.R. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:8627-8632.
37. Callicott J.H., Feighery E.L., Mattay V.S., White M.G., Chen Q., Baranger D.A., Berman K.F., Lu B., Song H., Ming G.L., Weinberger D.R. DISC1 and SLC12A2 interaction affects human hippocampal function and connectivity. J. Clin. Invest. 2013, 123:2961-2964.
38. Camargo L.M., Collura V., Rain J.C., Mizuguchi K., Hermjakob H., Kerrien S., Bonnert T.P., Whiting P.J., Brandon N.J. Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. Mol. Psychiatry 2007, 12:74-86.
39. Camarata S. Validity of early identification and early intervention in autism spectrum disorders: future directions. Int. J. Speech Lang. Pathol. 2014, 16:61-68.
40. Cantor-Graae E., Selten J.P. Schizophrenia and migration: a meta-analysis and review. Am. J. Psychiatry 2005, 162:12-24.
41. Carlyle B.C., Mackie S., Christie S., Millar J.K., Porteous D.J. Co-ordinated action of DISC1, PDE4B and GSK3β in modulation of cAMP signalling. Mol. Psychiatry 2011, 16:693-694.
42. Cash-Padgett T., Jaaro-Peled H. DISC1 mouse models as a tool to decipher gene-environment interactions in psychiatric disorders. Front. Behav. Neurosci. 2013, 7:113.
43. Cha J., Greenberg T., Carlson J.M., Dedora D.J., Hajcak G., Mujica-Parodi L.R. Circuit-wide structural and functional measures predict ventromedial prefrontal cortex fear generalization: implications for generalized anxiety disorder. J. Neurosci. 2014, 34:4043-4053.
44. Chamling X., Seo S., Bugge K., Searby C., Guo D.F., Drack A.V., Rahmouni K., Sheffield V.C. Ectopic expression of human BBS4 can rescue Bardet-Biedl syndrome phenotypes in Bbs4 null mice. PLOS ONE 2013, 8:e59101.
45. Chapman P.F., White G.L., Jones M.W., Cooper-Blacketer D., Marshall V.J., Irizarry M., Younkin L., Good M.A., Bliss T.V., Hyman B.T., Younkin S.G., Hsiao K.K. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 1999, 2:271-276.
46. Chaturvedi R.K., Flint Beal M. Mitochondrial diseases of the brain. Free Radic. Biol. Med. 2013, 63:1-29.
47. Cheah P.S., Ramshaw H.S., Thomas P.Q., Toyo-Oka K., Xu X., Martin S., Coyle P., Guthridge M.A., Stomski F., van den Buuse M., Wynshaw-Boris A., Lopez A.F., Schwarz Q.P. Neurodevelopmental and neuropsychiatric behaviour defects arise from 14-3-3ζ deficiency. Mol. Psychiatry 2012, 17:451-466.
48. Chelnokova O., Laeng B., Eikemo M., Riegels J., Løseth G., Maurud H., Willoch F., Leknes S. Rewards of beauty: the opioid system mediates social motivation in humans. Mol. Psychiatry 2014, (February). (Epub ahead of print).
49. Chen G., Chen K.S., Knox J., Inglis J., Bernard A., Martin S.J., Justice A., McConlogue L., Games D., Freedman S.B., Morris R.G. A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature 2000, 408:975-979.
50. Chishti M.A., Yang D.S., Janus C., Phinney A.L., Horne P., Pearson J., Strome R., Zuker N., Loukides J., French J., Turner S., Lozza G., Grilli M., Kunicki S., Morissette C., Paquette J., Gervais F., Bergeron C., Fraser P.E., Carlson G.A., George-Hyslop P.S., Westaway D. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein. J. Biol. Chem. 2001, 276:21562-21670.
51. Choi M.R., Hwang S., Park G.M., Jung K.H., Kim S.H., Das N.D., Chai Y.G. Effect of fluoxetine on the expression of tryptophan hydroxylase and 14-3-3 protein in the dorsal raphe nucleus and hippocampus of rat. J. Chem. Neuroanat. 2012, 43:96-102.
52. Chubb J.E., Bradshaw N.J., Soares D.C., Porteous D.J., Millar J.K. The DISC1 locus in psychiatric illness. Mol. Psychiatry 2008, 13:36-64.
53. Clapcote S.J., Lipina T.V., Millar J.K., Mackie S., Christie S., Ogawa F., Lerch J.P., Trimble K., Uchiyama M., Sakuraba Y., Kaneda H., Shiroishi T., Houslay M.D., Henkelman R.M., Sled J.G., Gondo Y., Porteous D.J., Roder J.C. Behavioral phenotypes of Disc1 missense mutations in mice. Neuron 2007, 54:387-402.
54. Clark-Elford R., Nathan P.J., Auyeung B., Voon V., Sule A., Müller U., Dudas R., Sahakian B.J., Phan K.L., Baron-Cohen S. The effects of oxytocin on social reward learning in humans. Int. J. Neuropsychopharmacol. 2014, 17:199-209.
55. Cole A.R. Glycogen synthase kinase 3 substrates in mood disorders and schizophrenia. FEBS J. 2013, 280:5213-5227.
56. Collins D.M., Murdoch H., Dunlop A.J., Charych E., Baillie G.S., Wang Q., Herberg F.W., Brandon N., Prinz A., Houslay M.D. Ndel1 alters its conformation by sequestering cAMP-specific phosphodiesterase-4D3 (PDE4D3) in a manner that is dynamically regulated through Protein Kinase A (PKA). Cell Signal. 2008, 20:2356-2369.
57. Corvin A., Donohoe G., Nangle J.M., Schwaiger S., Morris D., Gill M.A. Dysbindin risk haplotype associated with less severe manic-type symptoms in psychosis. Neurosci. Lett. 2008, 431:146-149.
58. Covington M.A., Lunden S.L., Cristofaro S.L., Wan C.R., Bailey C.T., Broussard B., Fogarty R., Johnson S., Zhang S., Compton M.T. Phonetic measures of reduced tongue movement correlate with negative symptom severity in hospitalized patients with first-episode schizophrenia-spectrum disorders. Schizophr. Res. 2012, 142:93-95.
59. Cox M.M., Tucker A.M., Tang J., Talbot K., Richer D.C., Yeh L., Arnold S.E. Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background. Genes Brain Behav. 2009, 8:390-397.
60. Crabbe J.C., Wahlsten D., Dudek B.C. Genetics of mouse behavior: interactions with laboratory environment. Science 1999, 284:1670-1672.
61. Crawley J.N. Behavioral phenotyping strategies for mutant mice. Neuron 2008, 57:809-818.
62. Cygnar K.D., Zhao H. Phosphodiesterase 1C is dispensable for rapid response termination of olfactory sensory neurons. Nat. Neurosci. 2009, 12:454-462.
63. Dalman C., Allebeck P., Gunnell D., Harrison G., Kristensson K., Lewis G., Lofving S., Rasmussen F., Wicks S., Karlsson H. Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects. Am. J. Psychiatry 2008, 165:59-65.
64. Dammermann A., Merdes A. Assembly of centrosomal proteins and microtubule organization depends on PCM-1. J. Cell Biol. 2002, 159:255-266.
65. Danoff S.K., Ross C.A. The inositol trisphosphate receptor gene family: implications for normal and abnormal brain function. Prog. Neuropsychopharmacol. Biol. Psychiatry 1994, 18:1-16.
66. Davis J.A., Gould T.J. Rolipram attenuates MK-801-induced deficits in latent inhibition. Behav. Neurosci. 2005, 119:595e602.
67. Defensor E.B., Corley M.J., Blanchard R.J., Blanchard D.C. Facial expressions of mice in aggressive and fearful contexts. Physiol. Behav. 2012, 107:680-685.
68. Derntl B., Seidel E.M., Schneider F., Habel U. How specific are emotional deficits? A comparison of empathic abilities in schizophrenia, bipolar and depressed patients. Schizophr. Res. 2012, 142:58-64.
69. Dickson D.W., Crystal H.A., Bevona C., Honer W., Vincent I., Davies P. Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol. Aging 1995, 16:285-298.
70. Domschke K., Lawford B., Young R., Voisey J., Morris C.P., Roehrs T., Hohoff C., Birosova E., Arolt V., Baune B.T. Dysbindin (DTNBP1) - a role in psychotic depression?. J. Psychiatr. Res. 2011, 45:588-595.
71. Duan X., Chang J.H., Ge S., Faulkner R.L., Kim J.Y., Kitabatake Y., Liu X.B., Yang C.H., Jordan J.D., Ma D.K., Liu C.Y., Ganesan S., Cheng H.J., Ming G.L., Lu B., Song H. Disrupted-In-Schizophrenia 1 regulates integration of newly generated neurons in the adult brain. Cell 2007, 130:1146-1158.
72. Dunsmoor J.E., Hs F., Zielinski D.J., Labar K.S. Extinction in multiple virtual reality contexts diminishes fear reinstatement in humans. Neurobiol. Learn. Mem. 2014, pii:S1074-7427(14)00043-4.
73. Eastwood S.L., Walker M., Hyde T.M., Kleinman J.E., Harrison P.J. The DISC1 Ser704Cys substitution affects centrosomal localization of its binding partner PCM1 in glia in human brain. Hum. Mol. Genet. 2010, 19:2487-2496.
74. Edwards V.J., Holden G.W., Felitti V.J., Anda R.F. Relationship between multiple forms of childhood maltreatment and adult mental health in community respondents: results from the adverse childhood experiences study. Am. J. Psychiatry 2003, 160:1453-1460.
75. Eichers E.R., Abd-El-Barr M.M., Paylor R., Lewis R.A., Bi W., Lin X., Meehan T.P., Stockton D.W., Wu S.M., Lindsay E., Justice M.J., Beales P.L., Katsanis N., Lupski J.R. Phenotypic characterization of Bbs4 null mice reveals age-dependent penetrance and variable expressivity. Hum. Genet. 2006, 120:211-226.
76. Ekelund J., Hovatta I., Parker A., Paunio T., Varilo T., Martin R., Suhonen J., Ellonen P., Chan G., Sinsheimer J.S., Sobel E., Juvonen H., Arajärvi R., Partonen T., Suvisaari J., Lönnqvist J., Meyer J., Peltonen L. Chromosome 1 loci in Finnish schizophrenia families. Hum. Mol. Genet. 2001, 10:1611-1617.
77. Ekelund J., Hennah W., Hiekkalinna T., Parker A., Meyer J., Lonnqvist J., Peltonen L. Replication of 1q42 linkage in Finnish schizophrenia pedigrees. Mol. Psychiatry 2004, 9:1037-1041.
78. Enomoto A., Asai N., Namba T., Wang Y., Kato T., Tanaka M., Tatsumi H., Taya S., Tsuboi D., Kuroda K., Kaneko N., Sawamoto K., Miyamoto R., Jijiwa M., Murakumo Y., Sokabe M., Seki T., Kaibuchi K., Takahashi M. Roles of disrupted-in-schizophrenia 1-interacting protein girdin in postnatal development of the dentate gyrus. Neuron 2009, 63:774-787.
79. Eykelenboom J.E., Briggs G.J., Bradshaw N.J., Soares D.C., Ogawa F., Christie S., Malavasi E.L., Makedonopoulou P., Mackie S., Malloy M.P., Wear M.A., Blackburn E.A., Bramham J., McIntosh A.M., Blackwood D.H., Muir W.J., Porteous D.J., Millar J.K. A t(1;11) translocation linked to schizophrenia and affective disorders gives rise to aberrant chimeric DISC1 transcripts that encode structurally altered, deleterious mitochondrial proteins. Hum. Mol. Genet. 2012, 21:3374-3386.
80. Fan X., Li D., Lichti C.F., Green T.A. Dynamic proteomics of nucleus accumbens in response to acute psychological stress in environmentally enriched and isolated rats. PLOS ONE 2013, 8:e73689.
81. Faulkner R.L., Jang M.H., Liu X.B., Duan X., Sailor K.A., Kim J.Y., Ge S., Jones E.G., Ming G.L., Song H., Cheng H.J. Development of hippocampal mossy fiber synaptic outputs by new neurons in the adult brain. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:14157-14162.
82. Flores R., Hirota Y., Armstrong B., Sawa A., Tomoda T. DISC1 regulates synaptic vesicle transport via a lithium-sensitive pathway. Neurosci. Res. 2011, 71:71-77.
83. Freyberg Z., Ferrando S.J., Javitch J.A. Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action. Am. J. Psychiatry 2010, 167:388-396.
84. Fujita T., Maturana A.D., Ikuta J., Hamada J., Walchli S., Suzuki T., Sawa H., Wooten M.W., Okajima T., Tatematsu K., Tanizawa K., Kuroda S. Axonal guidance protein FEZ1 associates with tubulin and kinesin motor protein to transport mitochondria in neurites of NGF-stimulated PC12 cells. Biochem. Biophys. Res. Commun. 2007, 361:605-610.
85. Fukuda T., Sugita S., Inatome R., Yanagi S. CAMDI, a novel disrupted in schizophrenia 1 (DISC1)-binding protein, is required for radial migration. J. Biol. Chem. 2010, 285:40554-40561.
86. Furley P., Dicks M., Memmert D. Nonverbal behavior in soccer: the influence of dominant and submissive body language on the impression formation and expectancy of success of soccer players. J. Sport Exerc. Psychol. 2012, 34:61-82.
87. Gao C., Hölscher C., Liu Y., Li L. GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease. Rev. Neurosci. 2011, 23:1-11.
88. Gould T.D., Einat H., Bhat R., Manji H.K. AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. Int. J. Neuropsychopharmacol. 2004, 7:387e390.
89. Green T.A., Alibhai I.N., Unterberg S., Neve R.L., Ghose S., Tamminga C.A., Nestler E.J. Induction of activating transcription factors (ATFs) ATF2, ATF3, and ATF4 in the nucleus accumbens and their regulation of emotional behavior. J. Neurosci. 2008, 28:2025-2232.
90. Grover D., Verma R., Goes F.S., Mahon P.L., Gershon E.S., McMahon F.J., Potash J.B., Gershon E.S., McMahon F.J., Potash J.B. Family-based association of YWHAH in psychotic bipolar disorder. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2009, 150:977-983. NIMH Genetics Initiative Bipolar Disorder Collaborative, Bipolar Disorder Phenome Group.
91. Guevara M.A., Rizo L., Ruiz-Díaz M., Hernández-González M. HANOIPC3: a computer program to evaluate executive functions. Comput. Methods Programs Biomed. 2009, 95:158-165.
92. Hamlin J.K., Mahajan N., Liberman Z., Wynn K. Not like me=bad: infants prefer those who harm dissimilar others. Psychol. Sci. 2013, 24:589-594.
93. Hamshere M.L., Bennett P., Williams N., Segurado R., Cardno A., Norton N., Lambert D., Williams H., Kirov G., Corvin A., Holmans P., Jones L., Jones I., Gill M., O'Donovan M.C., Owen M.J., Craddock N. Genome-wide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13. Arch. Gen. Psychiatry 2005, 62:1081-1088.
94. Haque F.N., Lipina T.V., Roder J.C., Wong A.H. Social defeat interacts with Disc1 mutations in the mouse to affect behavior. Behav. Brain Res. 2012, 233:337-344.
95. Hashimoto K., Fukushima T., Shimizu E., Okada S., Komatsu N., Okamura N., Koike K., Koizumi H., Kumakiri C., Imai K., Iyo M. Possible role of d-serine in the pathophysiology of Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 2004, 28:385-388.
96. Hashimoto R., Numakawa T., Ohnishi T., Kumamaru E., Yagasaki Y., Ishimoto T., Mori T., Nemoto K., Adachi N., Izumi A., Chiba S., Noguchi H., Suzuki T., Iwata N., Ozaki N., Taguchi T., Kamiya A., Kosuga A., Tatsumi M., Kamijima K., Weinberger D.R., Sawa A., Kunugi H. Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. Hum. Mol. Genet. 2006, 15:3024-3033.
97. Hattori S., Murotani T., Matsuzaki S., Ishizuka T., Kumamoto N., Takeda M., Tohyama M., Yamatodani A., Kunugi H., Hashimoto R. Behavioral abnormalities and dopamine reductions in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia. Biochem. Biophys. Res. Commun. 2008, 373:298-302.
98. Hayashi-Takagi A., Takaki M., Graziane N., Seshadri S., Murdoch H., Dunlop A.J., Makino Y., Seshadri A.J., Ishizuka K., Srivastava D.P., Xie Z., Baraban J.M., Houslay M.D., Tomoda T., Brandon N.J., Kamiya A., Yan Z., Penzes P., Sawa A. Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamatesynapse via Rac1. Nat. Neurosci. 2010, 13:327-332.
99. Hernandez F., Borrell J., Guaza C., Avila J., Lucas J.J. Spatial learning deficit in transgenic mice that conditionally over-express GSK-3beta in the brain but do not form tau filaments. J. Neurochem. 2002, 83:1529-1533.
100. Hernandez F., Lucas J.J., Avila J. GSK3 and tau: two convergence points in Alzheimer's disease. J. Alzheimer's Dis. 2013, 33:S141-S144.
101. Henry B.L., Minassian A., Young J.W., Paulus M.P., Geyer M.A., Perry W. Cross-species assessments of motor and exploratory behavior related to bipolar disorder. Neurosci. Biobehav. Rev. 2010, 34:1296-1306.
102. Hikida T., Jaaro-Peled H., Seshadri S., Oishi K., Hookway C., Kong S., Wu D., Xue R., Andradé M., Tankou S., Mori S., Gallagher M., Ishizuka K., Pletnikov M., Kida S., Sawa A. Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:14501-21456.
103. Hisatsune C., Miyamoto H., Hirono M., Yamaguchi N., Sugawara T., Ogawa N., Ebisui E., Ohshima T., Yamada M., Hensch T.K., Hattori M., Mikoshiba K. IP3R1 deficiency in the cerebellum/brainstem causes basal ganglia-independent dystonia by triggering tonic Purkinje cell firings in mice. Front. Neural Circ. 2013, 7:156.
104. Houslay M.D., Baillie G.S., Maurice D.H. cAMP-specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling. Circ. Res. 2007, 100:950-966.
105. Ibi D., Nagai T., Koike H., Kitahara Y., Mizoguchi H., Niwa M., Jaaro-Peled H., Nitta A., Yoneda Y., Nabeshima T., Sawa A., Yamada K. Combined effect of neonatal immune activation and mutant DISC1 on phenotypic changes in adulthood. Behav. Brain Res. 2010, 206:32-37.
106. Iijima T., Oqura H., Takatsuki K., Kawahara S., Wakabayashi K., Nakayama D., Fujioka M., Kimura Y. Impaired motor functions in mice lacking the RNA-binding protein Hzf. Neurosci. Res. 2007, 58(2):183-189.
107. Ikeda M., Hikita T., Taya S., Uraguchi-Asaki J., Toyo-oka K., Wynshaw-Boris A., Ujike H., Inada T., Takao K., Miyakawa T., Ozaki N., Kaibuchi K., Iwata N. Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia. Hum. Mol. Genet. 2008, 17:3212-3222.
108. Inaba Y., Niimi T., Nishimura T., Misawa Y., Fukuyama T., Higuchi T., Taki Y. Efficacy of visual cognitive function tests in health examinations of five-year-old children. No To Hattatsu 2013, 45:355-359.
109. Insel T.R. Rethinking schizophrenia. Nature 2010, 468:187-193.
110. Ishizuka K., Kamiya A., Oh E.C., Kanki H., Seshadri S., Robinson J.F., Murdoch H., Dunlop A.J., Kubo K., Furukori K., Huang B., Zeledon M., Hayashi-Takagi A., Okano H., Nakajima K., Houslay M.D., Katsanis N., Sawa A. DISC1-dependent switch from progenitor proliferation to migration in the developing cortex. Nature 2011, 473:92-96.
111. Iuculano T., Rosenberg-Lee M., Supekar K., Lynch C.J., Khouzam A., Phillips J., Uddin L.Q., Menon V. Brain organization underlying superior mathematical abilities in children with autism. Biol. Psychiatry 2014, 75:223-230.
112. Jaaro-Peled H., Niwa M., Foss C.A., Murai R., de Los Reyes S., Kamiya A., Mateo Y., O'Donnell P., Cascella N.G., Nabeshima T., Guilarte T.R., Pomper M.G., Sawa A. Subcortical dopaminergic deficits in a DISC1 mutant model: a study in direct reference to human molecular brain imaging. Hum. Mol. Genet. 2013, 22:1574-1580.
113. Jacobsen J.S., Wu C.C., Redwine J.M., Comery T.A., Arias R., Bowlby M., Martone R., Morrison J.H., Pangalos M.N., Reinhart P.H., Bloom F.E. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:5161-5166.
114. James R., Adams R.R., Christie S., Buchanan S.R., Porteous D.J., Millar J.K. Disrupted in Schizophrenia 1 (DISC1) is a multicompartmentalized protein that predominantly localizes to mitochondria. Mol. Cell Neurosci. 2004, 26:112-122.
115. Jessen H.M., Kolodkin M.H., Bychowski M.E., Auger C.J., Auger A.P. The nuclear receptor corepressor has organizational effects within the developing amygdala on juvenile social play and anxiety-like behavior. Endocrinology 2010, 151:1212-1220.
116. Johnson C., Wilbrecht L. Juvenile mice show greater flexibility in multiple choice reversal learning than adults. Dev. Cogn. Neurosci. 2011, 1:540-551.
117. Jordan R. Social play and autistic spectrum disorders: a perspective on theory, implications and educational approaches. Autism 2003, 7:347-360.
118. Kaidanovich-Beilin O., Lipina T.V., Takao K., van Eede M., Hattori S., Laliberté C., Khan M., Okamoto K., Chambers J.W., Fletcher P.J., MacAulay K., Doble B.W., Henkelman M., Miyakawa T., Roder J., Woodgett J.R. Abnormalities in brain structure and behavior in GSK-3alpha mutant mice. Mol. Brain 2009, 2:35.
119. Kakiuchi C., Ishiwata M., Nanko S., Kunugi H., Minabe Y., Nakamura K., Mori N., Fujii K., Yamada K., Yoshikawa T., Kato T. Association analysis of ATF4 and ATF5, genes for interacting-proteins of DISC1, in bipolar disorder. Neurosci. Lett. 2007, 417:316-321.
120. Kamiya A., Kubo K., Tomoda T., Takaki M., Youn R., Ozeki Y., Sawamura N., Park U., Kudo C., Okawa M., Ross C.A., Hatten M.E., Nakajima K., Sawa A. A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat. Cell Biol. 2005, 7:1167-1178.
121. Kamiya A., Tan P.L., Kubo K., Engelhard C., Ishizuka K., Kubo A., Tsukita S., Pulver A.E., Nakajima K., Cascella N.G., Katsanis N., Sawa A. Recruitment of PCM1 to the centrosome by the cooperative action of DISC1 and BBS4: a candidate for psychiatric illnesses. Arch. Gen. Psychiatry 2008, 65:996-1006.
122. Kanes S.J., Tokarczyk J., Siegel S.J., Bilker W., Abel T., Kelly M.P. Rolipram: a specific phosphodiestirase 4 inhibitor with potential antipsychotic activity. Neuroscience 2007, 144:239e246.
123. Kang E., Burdick K.E., Kim J.Y., Duan X., Guo J.U., Sailor K.A., Jung D.E., Ganesan S., Choi S., Pradhan D., Lu B., Avramopoulos D., Christian K., Malhotra A.K., Song H., Ming G.L. Interaction between FEZ1 and DISC1 in regulation of neuronal development and risk for schizophrenia. Neuron 2011, 72:559-571.
124. Kilpinen H., Ylisaukko-Oja T., Hennah W., Palo O.M., Varilo T., Vanhala R., Nieminen-von Wendt T., von Wendt L., Paunio T., Peltonen L. Association of DISC1 with autism and Asperger syndrome. Mol. Psychiatry 2008, 13:187-196.
125. Kim H.J., Park H.J., Jung K.H., Ban J.Y., Ra J., Kim J.W., Park J.K., Choe B.K., Yim S.V., Kwon Y.K., Chung J.H. Association study of polymorphisms between DISC1 and schizophrenia in a Korean population. Neurosci. Lett. 2008, 430:60-63.
126. Kim J.Y., Duan X., Liu C.Y., Jang M.H., Guo J.U., Pow-anpongkul N., Kang E., Song H., Ming G.L. DISC1 regulates new neuron development in the adult brain via modulation of AKT-mTOR signaling through KIAA1212. Neuron 2009, 63:761-773.
127. Kim J.Y., Liu C.Y., Zhang F., Duan X., Wen Z., Song J., Feighery E., Lu B., Rujescu D., St Clair D., Christian K., Callicott J.H., Weinberger D.R., Song H., Ming G.L. Interplay between DISC1 and GABA signaling regulates neurogenesis in mice and risk for schizophrenia. Cell 2012, 148(5):1051-1064.
128. Kimura T., Yamashita S., Nakao S., Park J.M., Murayama M., Mizoroki T., Yoshiike Y., Sahara N., Takashima A. GSK-3beta is required for memory reconsolidation in adult brain. PLOS ONE 2008, 3:e3540.
129. Kiraly D.D., Ma X.M., Mazzone C.M., Xin X., Mains R.E., Eipper B.A. Behavioral and morphological responses to cocaine require kalirin7. Biol. Psychiatry 2010, 68:249-255.
130. Kirkpatrick B., Xu L., Cascella N., Ozeki Y., Sawa A., Roberts R.C. DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex. J. Comp. Neurol. 2006, 497:436-450.
131. Kishimoto M., Ujike H., Motohashi Y., Tanaka Y., Okahisa Y., Kotaka T., Harano M., Inada T., Yamada M., Komiyama T., Hori T., Sekine Y., Iwata N., Sora I., Iyo M., Ozaki N., Kuroda S. The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis. Biol. Psychiatry 2008, 63:191-196.
132. Knobloch M., Konietzko U., Krebs D.C., Nitsch R.M. Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice. Neurobiol. Aging 2007, 28:1297-1306.
133. Koike H., Arguello P.A., Kvajo M., Karayiorgou M., Gogos J.A. Disc1 is mutated in the 129S6/SvEv strain and modulates working memory in mice. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:3693-3697.
134. Korth C. DISCopathies: brain disorders related to DISC1 dysfunction. Rev. Neurosci. 2009, 20:321-330.
135. Kvajo M., McKellar H., Arguello P.A., Drew L.J., Moore H., MacDermott A.B., Karayiorgou M., Gogos J.A. A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:7076-7081.
136. Kvajo M., Mckellar H., Drew L.J., Lepagnol-Bestel A.M., Xiao L., Levy R.J., Blazeski R., Arguello P.A., Lacefield C.O., Mason C.A., Simonneau M., O'donnell J.M., Macdermott A.B., Karayiorgou M., Gogos J.A. Altered axonal targeting and short-term plasticity in the hippocampus of Disc1 mutant mice. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:E1349-E1358.
137. Kubo K., Tomita K., Uto A., Kuroda K., Seshadri S., Cohen J., Kaibuchi K., Kamiya A., Nakajima K. Migration defects by DISC1 knockdown in C57BL/6, 129X1/SvJ, and ICR strains via in utero gene transfer and virus-mediated RNAi. Biochem. Biophys. Res. Commun. 2010, 400:631-637.
138. Kudryavtseva N.N., Bakshtanovskaya I.V., Koryakina L.A. Social model of depression in mice of C57BL/6J strain. Pharmacol. Biochem. Behav. 1991, 38:315-320.
139. Kuijpers M., Hoogenraad C.C. Centrosomes, microtubules and neuronal development. Mol. Cell Neurosci. 2011, 48:349-358.
140. Kuroda K., Yamada S., Tanaka M., Iizuka M., Yano H., Mori D., Tsuboi D., Nishioka T., Namba T., Iizuka Y., Kubota S., Nagai T., Ibi D., Wang R., Enomoto A., Isotani-Sakakibara M., Asai N., Kimura K., Kiyonari H., Abe T., Mizoguchi A., Sokabe M., Takahashi M., Yamada K., Kaibuchi K. Behavioral alterations associated with targeted disruption of exons 2 and 3 of the Disc1 gene in the mouse. Hum. Mol. Genet. 2011, 20:4666-4683.
141. Labrie V., Wong A.H., Roder J.C. Contributions of the d-serine pathway to schizophrenia. Neuropharmacology 2012, 62:1484-1503.
142. Labrie V., Fukumura R., Rastogi A., Fick L.J., Wang W., Boutros P.C., Kennedy J.L., Semeralul M.O., Lee F.H., Baker G.B., Belsham D.D., Barger S.W., Gondo Y., Wong A.H., Roder J.C. Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model. Hum. Mol. Genet. 2009, 18:3227-3343.
143. Lam C., Vergnolle M.A., Thorpe L., Woodman P.G., Allan V.J. Functional interplay between LIS1, NDE1 and NDEL1 in dynein-dependent organelle positioning. J. Cell Sci. 2010, 123:202-212.
144. Lee F.H., Fadel M.P., Preston-Maher K., Cordes S.P., Clapcote S.J., Price D.J., Roder J.C., Wong A.H. Disc1 point mutations in mice affect development of the cerebral cortex. J. Neurosci. 2011, 31:3197-3206.
145. Leggio L., Addolorato G., Cippitelli A., Jerlhag E., Kampov-Polevoy A.B., Swift R.M. Role of feeding-related pathways in alcohol dependence: a focus on sweet preference, NPY, and ghrelin. Alcohol. Clin. Exp. Res. 2011, 35:194-202.
146. Li C., Zheng Y., Qin W., Tao R., Pan Y., Xu Y., Li X., Gu N., Feng G., He L. A family-based association study of kinesin heavy chain member 2 gene (KIF2) and schizophrenia. Neurosci. Lett. 2006, 407:151-155.
147. Li W., Zhou Y., Jentsch J.D., Brown R.A., Tian X., Ehninger D., Hennah W., Peltonen L., Lönnqvist J., Huttunen M.O., Kaprio J., Trachtenberg J.T., Silva A.J., Cannon T.D. Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:18280-18285.
148. Li Y.F., Cheng Y.F., Huang Y., Conti M., Wilson S.P., O'Donnell J.M., Zhang H.T. Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling. J. Neurosci. 2011, 31:172-183.
149. Li S., Weerda R., Milde C., Wolf O.T., Thiel C.M. Effects of acute psychosocial stress on neural activity to emotional and neutral faces in a face recognition memory paradigm. Brain Imaging Behav. 2014, (January). (Epub ahead of print).
150. Licinio J., Wong M.L. A novel conceptual framework for psychiatry: vertically and horizontally integrated approaches to redundancy and pleiotropism that co-exist with a classification of symptom clusters based on DSM-5. Mol. Psychiatry 2013, 18:846-848.
151. Lima A.A., Fiszman A., Marques-Portella C., Mendlowicz M.V., Coutinho E.S., Maia D.C., Berger W., Rocha-Rego V., Volchan E., Mari J.J., Figueira I. The impact of tonic immobility reaction on the prognosis of posttraumatic stress disorder. J. Psychiatr. Res. 2010, 44:224-228.
152. Lin I.M., Fan S.Y., Huang T.L., Wu W.T., Li S.M. The associations between visual attention and facial expression identification in patients with schizophrenia. Psychiatry Invest. 2013, 10:393-398.
153. Lipina T., Roder J.C. A new model of the disrupted latent inhibition in C57BL/6J mice after bupropion treatment. Psychopharmacology (Berl.) 2010, 208:487-498.
154. Lipina T., Roder J.C. The genetic component of latent inhibition: studies of inbred and mutant mice. Latent Inhibition: Data, Theories, and Applications to Schizophrenia 2010, 225-251. Cambridge University Press, Cambridge, UK. R.E. Lubow, Ina Weiner (Eds.).
155. Lipina T.V., Niwa M., Jaaro-Peled H., Fletcher P.J., Seeman P., Sawa A., Roder J.C. Enhanced dopamine function in DISC1-L100P mutant mice: implications for schizophrenia. Genes Brain Behav. 2010, 9:777-789.
156. Lipina T.V., Kaidanovich-Beilin O., Patel S., Wang M., Clapcote S.J., Liu F., Woodgett J.R., Roder J.C. Genetic and pharmacological evidence for schizophrenia-related Disc1 interaction with GSK-3. Synapse 2011, 65:234-248.
157. Lipina T.V., Wang M., Liu F., Roder J.C. Synergistic interactions between PDE4B and GSK-3: DISC1 mutant mice. Neuropharmacology 2012, 62:1252-1262.
158. Lipina T.V., Palomo V., Gil C., Martinez A., Roder J.C. Dual inhibitor of PDE7 and GSK-3-VP1.15 acts as antipsychotic and cognitive enhancer in C57BL/6J mice. Neuropharmacology 2013, 64:205-214.
159. Lipina T.V., Fletcher P.J., Lee F.H., Wong A.H., Roder J.C. Disrupted-in-schizophrenia-1 Gln31Leu polymorphism results in social anhedonia associated with monoaminergic imbalance and reduction of CREB and β-arrestin-1,2 in the nucleus accumbens in a mouse model of depression. Neuropsychopharmacology 2013, 38:423-436.
160. Lipina T.V., Zai C., Hlousek D., Roder J.C., Wong A.H. Maternal immune activation during gestation interacts with Disc1 point mutation to exacerbate schizophrenia-related behaviors in mice. J. Neurosci. 2013, 33:7654-7666.
161. Liu Y.L., Fann C.S., Liu C.M., Chen W.J., Wu J.Y., Hung S.I., Chen C.H., Jou Y.S., Liu S.K., Hwang T.J., Hsieh M.H., Ouyang W.C., Chan H.Y., Chen J.J., Yang W.C., Lin C.Y., Lee S.F., Hwu H.G. A single nucleotide polymorphism fine mapping study of chromosome 1q42.1 reveals the vulnerability genes for schizophrenia, GNPAT and DISC1: association with impairment of sustained attention. Biol. Psychiatry 2006, 60:554-562.
162. López R., Poy R., Patrick C.J., Moltó J. Deficient fear conditioning and self-reported psychopathy: the role of fearless dominance. Psychophysiology 2013, 50:210-218.
163. Lovestone S., Killick R., Di Forti M., Murray R. Schizophrenia as a GSK-3 dysregulation disorder. Trends Neurosci. 2007, 30:142-149.
164. Löw A., Lang P.J., Smith J.C., Bradley M.M. Both predator and prey: emotional arousal in threat and reward. Psychol. Sci. 2008, 19:865-873.
165. Lubow R.E., Moore A.U. Latent inhibition: the effect of non-reinforced preexposure to the conditioned stimulus. J. Comp. Physiol. Psychol. 1959, 52:415-419.
166. Ma X.M., Kiraly D.D., Gaier E.D., Wang Y., Kim E.J., Levine E.S., Eipper B.A., Mains R.E. Kalirin-7 is required for synaptic structure and function. J. Neurosci. 2008, 28:12368-12382.
167. Ma T.M., Abazyan S., Abazyan B., Nomura J., Yang C., Seshadri S., Sawa A., Snyder S.H., Pletnikov M.V. Pathogenic disruption of DISC1-serine racemase binding elicits schizophrenia-like behavior via d-serine depletion. Mol. Psychiatry 2013, 18:557-567.
168. Macgregor S., Visscher P.M., Knott S.A., Thomson P., Porteous D.J., Millar J.K., Devon R.S., Blackwood D., Muir W.J. A genome scan and follow-up study identify a bipolar disorder susceptibility locus on chromosome 1q42. Mol. Psychiatry 2004, 9:1083-1090.
169. Maher B.J., Loturco J.J. Disrupted-in-schizophrenia (DISC1) functions presynaptically at glutamatergic synapses. PLOS ONE 2012, 7:e34053.
170. Malkesman O., Scattoni M.L., Paredes D., Tragon T., Pearson B., Shaltiel G., Chen G., Crawley J.N., Manji H.K. The female urine sniffing test: a novel approach for assessing reward-seeking behavior in rodents. Biol. Psychiatry 2010, 67:864-871.
171. Mathieson I., Munafo M.R., Flint J. Meta-analysis indicates that common variants at the DISC1 locus are not associated with schizophrenia. Mol. Psychiatry 2012, 17:634-641.
172. Mao Y., Ge X., Frank C.L., Madison J.M., Koehler A.N., Doud M.K., Tassa C., Berry E.M., Soda T., Singh K.K., Biechele T., Petryshen T.L., Moon R.T., Haggarty S.J., Tsai L.H. Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signalling. Cell 2009, 136:1017-1031.
173. Marcus D.K., Fulton J.J., Edens J.F. The two-factor model of psychopathic personality: evidence from the psychopathic personality inventory. Personal Disord. 2013, 4:67-76.
174. Maren S., Phan K.L., Liberzon I. The contextual brain: implications for fear conditioning, extinction and psychopathology. Nat. Rev. Neurosci. 2013, 14:417-428.
175. Martinez A., Perez D.I., Gil C. Lessons learnt from glycogen synthase kinase 3 inhibitors development for Alzheimer's disease. Curr. Top. Med. Chem. 2013, 13:1808-1819.
176. Marvel C.L., Paradiso S. Cognitive and neurological impairment in mood disorders. Psychiatr. Clin. North. Am. 2004, 27:19-36.
177. Maxwell C.R., Kanes S.J., Abel T., Siegel S.J. Phosphodiesterase inhibitors: a novel mechanisms for receptor-independent antipsychotic medications. Neuroscience 2004, 129:101e107.
178. McGue M., Gottesman I.I. Genetic linkage in schizophrenia: perspectives from genetic epidemiology. Schizophr. Bull. 1989, 15:453-464.
179. McManus E.J., Sakamoto K., Armit L.J., Ronaldson L., Shpiro N., Marquez R., Alessi D.R. Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. EMBO J. 2005, 24:1571-1583.
180. Meyer U., Yee B.K., Feldon J. The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse?. Neuroscientist 2007, 13:241-256.
181. Meyer U., Feldon J. To poly(I:C) or not to poly(I:C): advancing preclinical schizophrenia research through the use of prenatal immune activation models. Neuropharmacology 2012, 62:1308-1321.
182. Milad M.R., Furtak S.C., Greenberg J.L., Keshaviah A., Im J.J., Falkenstein M.J., Jenike M., Rauch S.L., Wilhelm S. Deficits in conditioned fear extinction in obsessive-compulsive disorder and neurobiological changes in the fear circuit. JAMA Psychiatry 2013, 70:608-618.
183. Millar J.K., Wilson-Annan J.C., Anderson S., Christie S., Taylor M.S., Semple C.A., Devon R.S., St Clair D.M., Muir W.J., Blackwood D.H., Porteous D.J. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum. Mol. Genet. 2000, 9:1415-1423.
184. Millar J.K., Christie S., Anderson S., Lawson D., Hsiao-Wei Loh D., Devon R.S., Arveiler B., Muir W.J., Blackwood D.H., Porteous D.J. Genomic structure and localisation within a linkage hotspot of Disrupted In Schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia. Mol. Psychiatry 2001, 6:173-178.
185. Millar J.K., Pickard B.S., Mackie S., James R., Christie S., Buchanan S.R., Malloy M.P., Chubb J.E., Huston E., Baillie G.S., Thomson P.A., Hill E.V., Brandon N.J., Rain J.C., Camargo L.M., Whiting P.J., Houslay M.D., Blackwood D.H., Muir W.J., Porteous D.J. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 2005, 310:1187-1191.
186. Miyazaki S., Ishikawa F., Fujikawa T., Nagata S., Yamaguchi K. Intraperitoneal injection of lipopolysaccharide induces dynamic migration of Gr-1 high polymorphonuclear neutrophils in the murine abdominal cavity. Clin. Diagn. Lab. Immunol. 2004, 11:452-457.
187. Miyoshi K., Honda A., Baba K., Taniguchi M., Oono K., Fujita T., Kuroda S., Katayama T., Tohyama M. Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth. Mol. Psychiatry 2003, 8:685-694.
188. Miyoshi K., Asanuma M., Miyazaki I., Diaz-Corrales F.J., Katayama T., Tohyama M., Ogawa N. DISC1 localizes to the centrosome by binding to kendrin. Biochem. Biophys. Res. Commun. 2004, 317:1195-1199.
189. Moller P., Husby R. The initial prodrome in schizophrenia: searching for naturalistic core dimensions of experience and behavior. Schizophr. Bull. 2000, 26:217-232.
190. Morein-Zamir S., Craig K.J., Ersche K.D., Abbott S., Muller U., Fineberg N.A., Bullmore E.T., Sahakian B.J., Robbins T.W. Impaired visuospatial associative memory and attention in obsessive compulsive disorder but no evidence for differential dopaminergic modulation. Psychopharmacology (Berl.) 2010, 212:357-367.
191. Morgan A. Speech-language pathology insights into genetics and neuroscience: beyond surface behaviour. Int. J. Speech Lang. Pathol. 2013, 15:245-254.
192. Morris J.A., Kandpal G., Ma L., Austin C.P. DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation. Hum. Mol. Genet. 2003, 12:1591-1608.
193. Murdoch H., Mackie S., Collins D.M., Hill E.V., Bolger G.B., Klussmann E., Porteous D.J., Millar J.K., Houslay M.D. Isoform-selective susceptibility of DISC1/phosphodiesterase-4 complexes to dissociation by elevated intracellular cAMP levels. J. Neurosci. 2007, 27:9513-9524.
194. Murdoch H., Vadrevu S., Prinz A., Dunlop A.J., Klussmann E., Bolger G.B., Norman J.C., Houslay M.D. Interaction between LIS1 and PDE4, and its role in cytoplasmic dynein function. J. Cell Sci. 2011, 124:2253-2266.
195. Morton J.B., Bosma R., Ansari D. Age-related changes in brain activation associated with dimensional shifts of attention: an fMRI study. Neuroimage 2009, 46:249-256.
196. Nagai T., Kitahara Y., Ibi D., Nabeshima T., Sawa A., Yamada K. Effects of antipsychotics on the behavioral deficits in human dominant-negative DISC1 transgenic mice with neonatal polyI:C treatment. Behav. Brain Res. 2011, 225:305-310.
197. Najavits L.M. Therapy for posttraumatic stress and alcohol dependence. JAMA 2013, 310:2457-2468.
198. Namba T., Ming G.L., Song H., Waga C., Enomoto A., Kaibuchi K., Kohsaka S., Uchino S. NMDA receptor regulates migration of newly generated neurons in the adult hippocampus via Disrupted-In-Schizophrenia 1 (DISC1). J. Neurochem. 2011, 118:34-44.
199. Neal A.P., Guilarte T.R. Molecular neurobiology of lead (Pb(2+)): effects on synaptic function. Mol. Neurobiol. 2010, 42:151-160.
200. Nestler E.J., Hyman S.E. Animal models of neuropsychiatric disorders. Nat. Neurosci. 2010, 13:1161-1169.
201. Ng M.Y., Levinson D.F., Faraone S.V., Suarez B.K., DeLisi L.E., Arinami T., et al. Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol. Psychiatry 2009, 14:774-785.
202. Nicodemus K.K., Callicott J.H., Higier R.G., Luna A., Nixon D.C., Lipska B.K., Vakkalanka R., Giegling I., Rujescu D., St Clair D., Muglia P., Shugart Y.Y., Weinberger D.R. Evidence of statistical epistasis between DISC1, CIT and NDEL1 impacting risk for schizophrenia: biological validation with functional neuroimaging. Hum. Genet. 2010, 127:441-452.
203. Nigg E.A., Raff J.W. Centrioles, centrosomes, and cilia in health and disease. Cell 2009, 139:663-678.
204. Niwa M., Kamiya A., Murai R., Kubo K., Gruber A.J., Tomita K., Lu L., Tomisato S., Jaaro-Peled H., Seshadri S., Hiyama H., Huang B., Kohda K., Noda Y., O'Donnell P., Nakajima K., Sawa A., Nabeshima T. Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits. Neuron 2010, 65:480-489.
205. Niwa M., Jaaro-Peled H., Tankou S., Seshadri S., Hikida T., Matsumoto Y., Cascella N.G., Kano S., Ozaki N., Nabeshima T., Sawa A. Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids. Science 2013, 339:335-339.
206. Noble W., Planel E., Zehr C., Olm V., Meyerson J., Suleman F., Gaynor K., Wang L., LaFrancois J., Feinstein B., Burns M., Krishnamurthy P., Wen Y., Bhat R., Lewis J., Dickson D., Duff K. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:69906995.
207. O'Brien W.T., Harper A.D., Jové F., Woodgett J.R., Maretto S., Piccolo S., Klein P.S. Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium. J. Neurosci. 2004, 24:6791-6798.
208. O'Donnell J.M., Zhang H.T. Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4). Trends Pharmacol. Sci. 2004, 25:158e163.
209. Ogura H., Matsumoto M., Mikoshiba K. Motor discoordination in mutant mice heterozygous for the type 1 inositol 1,4,5-trisphosphate receptor. Behav. Brain Res. 2001, 122:215-219.
210. Olff M., Frijling J.L., Kubzansky L.D., Bradley B., Ellenbogen M.A., Cardoso C., Bartz J.A., Yee J.R., van Zuiden M. The role of oxytocin in social bonding, stress regulation and mental health: an update on the moderating effects of context and interindividual differences. Psychoneuroendocrinology 2013, 38:1883-1894.
211. Oliver P.L. Challenges of analysing gene-environment interactions in mouse models of schizophrenia. Sci. World J. 2011, 11:1411-1420.
212. Olsson A., Nearing K.I., Phelps E.A. Learning fears by observing others: the neural systems of social fear transmission. Soc. Cogn. Affect. Neurosci. 2007, 2:3-11.
213. Onishi T., Iwashita H., Uno Y., Kunitomo J., Saitoh M., Kimura E., Fujita H., Uchiyama N., Kori M., Takizawa M. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S)-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadia-zole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease. J. Neurochem. 2011, 119:1330-1340.
214. Opler M.G., Buka S.L., Groeger J., McKeague I., Wei C., Factor-Litvak P., Bresnahan M., Graziano J., Goldstein J.M., Seidman L.J., Brown A.S., Susser E.S. Prenatal exposure to lead, delta-aminolevulinic acid, and schizophrenia: further evidence. Environ. Health Perspect. 2008, 116:1586-1590.
215. Palo O.M., Antila M., Silander K., Hennah W., Kilpinen H., Soronen P., Soronen P., Tuulio-Henriksson A., Kieseppä T., Partonen T., Lönnqvist J., Peltonen L., Paunio T. Association of distinct allelic haplotypes of DISC1 with psychotic and bipolar spectrum disorders and with underlying cognitive impairments. Hum. Mol. Genet. 2007, 16:2517-2528.
216. Panksepp J., Siviy S., Normansell L. The psychobiology of play: theoretical and methodological perspectives. Neurosci. Biobehav. Rev. 1984, 8:465-492.
217. Park Y.U., Jeong J., Lee H., Mun J.Y., Kim J.H., Lee J.S., Nguyen M.D., Han S.S., Suh P.G., Park S.K. Disrupted-in-schizophrenia 1 (DISC1) plays essential roles in mitochondria in collaboration with Mitofilin. Proc. Natl. Acad. Sci. U.S.A 2010, 107:17785-17790.
218. Paspalas C.D., Wang M., Arnsten A.F. Constellation of HCN channels and cAMP regulating proteins in dendritic spines of the primate prefrontal cortex: potential substrate for working memory deficits in schizophrenia. Cereb. Cortex 2013, 23:1643-1654.
219. Paylor R., Hirotsune S., Gambello M.J., Yuva-Paylor L., Crawley J.N., Wynshaw-Boris A. Impaired learning and motor behavior in heterozygous Pafah1b1 (Lis1) mutant mice. Learn. Mem. 1999, 6:521-537.
220. Pedersen C.B., Mortensen P.B. Are the cause(s) responsible for urban-rural differences in schizophrenia risk rooted in families or in individuals. Am. J. Epidemiol. 2006, 163:971-978.
221. Peineau S., Nicolas C.S., Bortolotto Z.A., Bhat R.V., Ryves W.J., Harwood A.J., Dournaud P., Fitzjohn S.M., Collingridge G.L. A systematic investigation of the protein kinases involved in NMDA receptor-dependent LTD: evidence for a role of GSK-3 but not other serine/threonine kinases. Mol. Brain 2009, 2:22.
222. Pletnikov M.V., Ayhan Y., Nikolskaia O., Xu Y., Ovanesov M.V., Huang H., Mori S., Moran T.H., Ross C.A. Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol. Psychiatry 2008, 13:173-186.
223. Pogorelov V.M., Nomura J., Kim J., Kannan G., Ayhan Y., Yang C., Taniguchi Y., Abazyan B., Valentine H., Krasnova I.N., Kamiya A., Cadet J.L., Wong D.F., Pletnikov M.V. Mutant DISC1 affects methamphetamine-induced sensitization and conditioned place preference: a comorbidity model. Neuropharmacology 2012, 62:1242-1251.
224. Polter A., Beurel E., Yang S., Garner R., Song L., Miller C.A., Sweatt J.D., McMahon L., Bartolucci A.A., Li X., Jope R.S. Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances. Neuropsychopharmacology 2010, 35:1761-1774.
225. Porteous D.J., Millar J.K., Brandon N.J., Sawa A. DISC1 at 10: connecting psychiatric genetics and neuroscience. Trends Mol. Med. 2011, 17:699-706.
226. Potkin S.G., Turner J.A., Guffanti G., Lakatos A., Fallon J.H., Nguyen D.D., Mathalon D., Ford J., Lauriello J., Macciardi F. A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype. Schizophr. Bull. 2009, 35:96-108. FBIRN.
227. Powell C.M., Miyakawa T. Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder?. Biol. Psychiatry 2006, 59:1198-1207.
228. Prickaerts J., Moechars D., Cryns K., Lenaerts I., van Craenendonck H., Goris I., Daneels G., Bouwknecht J.A., Steckler T. Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania. J. Neurosci. 2006, 26:9022-9029.
229. Qu M., Tang F., Wang L., Yan H., Han Y., Yan J., Yue W., Zhang D. Associations of ATF4 gene polymorphisms with schizophrenia in male patients. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2008, 147B:732-736.
230. Ramsey A.J., Milenkovic M., Oliveira A.F., Escobedo-Lozoya Y., Seshadri S., Salahpour A., Sawa A., Yasuda R., Caron M.G. Impaired NMDA receptor transmission alters striatal synapses and DISC1 protein in an age-dependent manner. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:5795-5800.
231. Rastogi A., Zai C., Likhodi O., Kennedy J.L., Wong A.H. Genetic association and post-mortem brain mRNA analysis of DISC1 and related genes in schizophrenia. Schizophr. Res. 2009, 114:39-49.
232. Rock E.M., Benzaquen J., Limebeer C.L., Parker L.A. Potential of the rat model of conditioned gaping to detect nausea produced by rolipram, a phosphodiesterase-4 (PDE4) inhibitor. Pharmacol. Biochem. Behav. 2009, 91:537-541.
233. Rutten K., Prickaerts J., Blokland A. Rolipram reverses scopolamine-induced and time-dependent memory deficits in object recognition by different mechanisms of action. Neurobiol. Learn. Mem. 2006, 85:132-138.
234. Rutten K., Misner D.L., Works M., Blokland A., Novak T.J., Santarelli L., Wallace T.L. Enhanced long-term potentiation and impaired learning in phosphodiesterase 4D-knockout (PDE4D) mice. Eur. J. Neurosci. 2008, 28:625-632.
235. Sakae N., Yamasaki N., Kitaichi K., Fukuda T., Yamada M., Yoshikawa H., Hiranita T., Tatsumi Y., Kira J., Yamamoto T., Miyakawa T., Nakayama K.I. Mice lacking the schizophrenia-associated protein FEZ1 manifest hyperactivity and enhanced responsiveness to psychostimulants. Hum. Mol. Genet. 2008, 17:3191-3203.
236. Sasaki S., Shionoya A., Ishida M., Gambello M.J., Yingling J., Wynshaw-Boris A., Hirotsune S. A LIS1/NUDEL/cytoplasmic dynein heavy chain complex in the developing and adult nervous system. Neuron 2000, 28:681-696.
237. Sawamura N., Sawamura-Yamamoto T., Ozeki Y., Ross C.A., Sawa A. A form of DISC1 enriched in nucleus: altered subcellular distribution in orbitofrontal cortex in psychosis and substance/alcohol abuse. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:1187-1192.
238. Sawamura N., Ando T., Maruyama Y., Fujimuro M., Mochizuki H., Honjo K., Shimoda M., Toda H., Sawamura-Yamamoto T., Makuch L.A., Hayashi A., Ishizuka K., Cascella N.G., Kamiya A., Ishida N., Tomoda T., Hai T., Furukubo-Tokunaga K., Sawa A. Nuclear DISC1 regulates CRE-mediated gene transcription and sleep homeostasis in the fruit fly. Mol. Psychiatry 2008, 13:1138-1148.
239. Scattoni M.L., Crawley J., Ricceri L. Ultrasonic vocalizations: a tool for behavioural phenotyping of mouse models of neurodevelopmental disorders. Neurosci. Biobehav. Rev. 2009, 33:508-515.
240. Schaeffer E.L., Figueiro M., Gattaz W.F. Insights into Alzheimer disease pathogenesis from studies in transgenic animal models. Clinics (Sao Paulo) 2011, 66:45-54.
241. Shen S., Lang B., Nakamoto C., Zhang F., Pu J., Kuan S.L., Chatzi C., He S., Mackie I., Brandon N.J., Marquis K.L., Day M., Hurko O., McCaig C.D., Riedel G., St Clair D. Schizophrenia-related neural and behavioral phenotypes in transgenic mice expressing truncated Disc1. J. Neurosci. 2008, 28:10893-10904.
242. Shi L., Fatemi S.H., Sidwell R.W., Patterson P.H. Maternal influenza infection causes marked behavioural and pharmacological changes in the offspring. J. Neurosci. 2003, 23:297-302.
243. Shimizu S., Matsuzaki S., Hattori T., Kumamoto N., Miyoshi K., Katayama T., Tohyama M. DISC1-kendrin interaction is involved in centrosomal microtubule network formation. Biochem. Biophys. Res. Commun. 2008, 377:1051-1056.
244. Shinoda T., Taya S., Tsuboi D., Hikita T., Matsuzawa R., Kuroda S., Iwamatsu A., Kaibuchi K. DISC1 regulates neurotrophin-induced axon elongation via interaction with Grb2. J. Neurosci. 2007, 27:4-14.
245. Shoji H., Toyama K., Takamiya Y., Wakana S., Gondo Y., Miyakawa T. Comprehensive behavioral analysis of ENU-induced Disc1-Q31L and -L100P mutant mice. BMC Res. Notes 2012, 5:108.
246. Singh K.K., Ge X., Mao Y., Drane L., Meletis K., Samuels B.A., Tsai L.H. Dixdc1 is a critical regulator of DISC1 and embryonic cortical development. Neuron 2010, 67:33-48.
247. Singh K.K., De Rienzo G., Drane L., Mao Y., Flood Z., Madison J., Ferreira M., Bergen S., King C., Sklar P., Sive H., Tsai L.H. Common DISC1 polymorphisms disrupt Wnt/GSK3beta signaling and brain development. Neuron 2011, 72:545-558.
248. Siuciak J.A., McCarthy S.A., Chapin D.S., Martin A.N. Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-4B (PDE4B) enzyme. Psychopharmacology (Berl.) 2008, 197:115-126.
249. Siviy S.M., Panksepp J. In search of the neurobiological substrates for social playfulness in mammalian brains. Neurosci. Biobehav. Rev. 2011, 35:1821-1830.
250. Sluik D., van Lee L., Geelen A., Feskens E.J. Alcoholic beverage preference and diet in a representative Dutch population: the Dutch national food consumption survey 2007-2010. Eur. J. Clin. Nutr. 2014, (January). (Epub ahead of print).
251. Smutzer G., Patel J.Y., Stull J.C., Abarintos R.A., Khan N.K., Park K.C. A preference test for sweet taste that uses edible strips. Appetite 2014, 73:132-139.
252. Soda T., Frank C., Ishizuka K., Baccarella A., Park Y.U., Flood Z., Park S.K., Sawa A., Tsai L.H. DISC1-ATF4 transcriptional repression complex: dual regulation of the cAMP-PDE4 cascade by DISC1. Mol. Psychiatry 2013, (April). 10.1038/mp.2013.38.
253. Sokolowska E., Hovatta I. Anxiety genetics - findings from cross-species genome-wide approaches. Biol. Mood Anxiety Disord. 2013, 3:9.
254. St Clair D., Blackwood D., Muir W., Carothers A., Walker M., Spowart G., Gosden C., Evans H.J. Association within a family of a balanced autosomal translocation with major mental illness. Lancet 1990, 336:13-16.
255. Steinecke A., Gampe C., Valkova C., Kaether C., Bolz J. Disrupted-in-Schizophrenia 1 (DISC1) is necessary for the correct migration of cortical interneurons. J. Neurosci. 2012, 32:738-745.
256. Stewart S., Cacucci F., Lever C. Which memory task for my mouse? A systematic review of spatial memory performance in the Tg2576 Alzheimer's mouse model. J. Alzheimers Dis. 2011, 26:105-126.
257. Swerdlow N.R., Weber M., Qu Y., Light G.A., Braff D.L. Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology (Berl.) 2008, 199:331-388.
258. Takao K., Toyama K., Nakanishi K., Hattori S., Takamura H., Takeda M., Miyakawa T., Hashimoto R. Impaired long-term memory retention and working memory in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia. Mol. Brain 2008, 1:11.
259. Taya S., Shinoda T., Tsuboi D., Asaki J., Nagai K., Hikita T., Kuroda S., Kuroda K., Shimizu M., Hirotsune S., Iwamatsu A., Kaibuchi K. DISC1 regulates the transport of the NUDEL/LIS1/14-3-3epsilon complex through kinesin-1. J. Neurosci. 2007, 27:15-26.
260. Taylor M.S., Devon R.S., Millar J.K., Porteous D.J. Evolutionary constraints on the disrupted in Schizophrenia locus. Genomics 2003, 81:67-77.
261. Terburg D., Hooiveld N., Aarts H., Kenemans J.L., van Honk J. Eye tracking unconscious face-to-face confrontations: dominance motives prolong gaze to masked angry faces. Psychol. Sci. 2011, 22:314-319.
262. Thomason M.E., Race E., Burrows B., Whitfield-Gabrieli S., Glover G.H., Gabrieli J.D. Development of spatial and verbal working memory capacity in the human brain. J. Cogn. Neurosci. 2009, 21:316-332.
263. Thomson P.A., Wray N.R., Millar J.K., Evans K.L., Hellard S.L., Condie A., Muir W.J., Blackwood D.H., Porteous D.J. Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population. Mol. Psychiatry 2005, 10:657-668.
264. Thomson P.A., Malavasi E.L., Grünewald E., Soares D.C., Borkowska M., Millar J.K. DISC1 genetics, biology and psychiatric illness. Front. Biol. 2013, 8:1-31.
265. Tran A.N., Ornelas I.J., Kim M., Perez G., Green M., Lyn M.J., Corbie-Smith G. Results from a pilot promotora program to reduce depression and stress among immigrant latinas. Health Promot. Pract. 2013, (December). (Epub ahead of print).
266. Tseng H.H., Chen S.H., Liu C.M., Howes O., Huang Y.L., Hsieh M.H., Liu C.C., Shan J.C., Lin Y.T., Hwu H.G. Facial and prosodic emotion recognition deficits associate with specific clusters of psychotic symptoms in schizophrenia. PLOS ONE 2013, 8:e66571.
267. Valiente M., Martini F.J. Migration of cortical interneurons relies on branched leading process dynamics. Cell Adhes. Migr. 2009, 3:278-280.
268. Valvezan A.J., Klein P.S. GSK-3 and Wnt signaling in neurogenesis and bipolar disorder. Front. Mol. Neurosci. 2012, 5:1.
269. Van Dam D., D'Hooge R., Staufenbiel M., Van Ginneken C., Van Meir F., De Deyn P.P. Age-dependent cognitive decline in the APP23 model precedes amyloid deposition. Eur. J. Neurosci. 2003, 17:388-396.
270. Vieta E., Valentí M. Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis. CNS Drugs 2013, 27:515-529.
271. Vöhringer P.A., Barroilhet S.A., Amerio A., Reale M.L., Alvear K., Vergne D., Ghaemi S.N. Cognitive impairment in bipolar disorder and schizophrenia: a systematic review. Front. Psychiatry 2013, 4:87.
272. Vyas A., Kim S.K., Giacomini N., Boothroyd J.C., Sapolsky R.M. Behavioral changes induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:6442-6447.
273. Walsh J., Desbonnet L., Clarke N., Waddington J.L., O'Tuathaigh C.M. Disruption of exploratory and habituation behavior in mice with mutation of DISC1: an ethologically based analysis. J. Neurosci. Res. 2012, 90:1445-1453.
274. Wang Q., Charych E.I., Pulito V.L., Lee J.B., Graziane N.M., Crozier R.A., Revilla-Sanchez R., Kelly M.P., Dunlop A.J., Murdoch H., Taylor N., Xie Y., Pausch M., Hayashi-Takagi A., Ishizuka K., Seshadri S., Bates B., Kariya K., Sawa A., Weinberg R.J., Moss S.J., Houslay M.D., Yan Z., Brandon N.J. The psychiatric disease risk factors DISC1 and TNIK interact to regulate synapse composition and function. Mol. Psychiatry 2011, 16:1006-1023.
275. Wang H., Yang H., Shivalila C.S., Dawlaty M.M., Cheng A.W., Zhang F., Jaenisch R. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 2013, 153:910-918.
276. Watatani Y., Ichikawa K., Nakanishi N., Fujimoto M., Takeda H., Kimura N., Hirose H., Takahashi S., Takahashi Y. Stress-induced translation of ATF5 mRNA is regulated by the 5'-untranslated region. J. Biol. Chem. 2008, 283:2543-2553.
277. Watson P.J., Fairall L., Schwabe J.W. Nuclear hormone receptor co-repressors: structure and function. Mol. Cell. Endocrinol. 2012, 348:440-449.
278. Weaver I.C., Cervoni N., Champagne F.A., D'alessio A.C., Sharma S., Seckl J.R., Dymov S., Szyf M., Meaney M.J. Epigenetic programming by maternal behavior. Nat. Neurosci. 2004, 7:847-854.
279. Wei J., Graziane N.M., Wang H., Zhong P., Wang Q., Liu W., Hayashi-Takagi A., Korth C., Sawa A., Brandon N.J., Yan Z. Regulation of N-methyl-d-aspartate receptors by disrupted-in-schizophrenia-1. Biol. Psychiatry 2014, 75:414-424.
280. Weiner I. The two-headed latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology (Berl.) 2003, 169:257-297.
281. Weiner I., Arad M. Using the pharmacology of latent inhibition to model domains of pathology in schizophrenia and their treatment. Behav. Brain Res. 2009, 204:369-386.
282. Weigelt S., Koldewyn K., Kanwisher N. Face recognition deficits in autism spectrum disorders are both domain specific and process specific. PLOS ONE 2013, 8:e74541.
283. Whiteford H.A., Degenhardt L., Rehm J., Baxter A.J., Ferrari A.J., Erskine H.E., Charlson F.J., Norman R.E., Flaxman A.D., Johns N., Burstein R., Murray C.J., Vos T. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study. Lancet 2010, 382:1575-1586.
284. WHO International Consortium in Psychiatric Epidemiology Cross-national comparisons of the prevalences and correlates of mental disorders. Bull. World Health Organ. 2000, 78(4):413-426.
285. Wilkins L.K., Girard T.A., King J., King M.J., Herdman K.A., Christensen B.K., King J. Spatial-memory deficit in schizophrenia spectrum disorders under viewpoint-independent demands in the virtual courtyard task. J. Clin. Exp. Neuropsychol. 2013, 35:1082-1093.
286. Willner P. The validity of animal models of depression. Psychopharmacology (Berl.) 1984, 83:1-16.
287. Woodgett J.R. Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J. 1990, 9:2431-2438.
288. Wöhr M., Scattoni M.L. Behavioural methods used in rodent models of autism spectrum disorders: current standards and new developments. Behav. Brain Res. 2013, 251:5-17.
289. Wu D., Pan W. GSK3: a multifaceted kinase in Wnt signaling. Trends Biochem. Sci. 2010, 35:161-168.
290. Wu C.C., Wick F.A., Pomplun M. Guidance of visual attention by semantic information in real-world scenes. Front. Psychol. 2014, 5:54.
291. Wynshaw-Boris A. Lissencephaly and LIS1: insights into the molecular mechanisms of neuronal migration and development. Clin. Genet. 2007, 72:296-304.
292. Xia C.H., Roberts E.A., Her L.S., Liu X., Williams D.S., Cleveland D.W., Goldstein L.S. Abnormal neurofilament transport caused by targeted disruption of neuronal kinesin heavy chain KIF5A. J. Cell Biol. 2003, 161:55-66.
293. Xu F., Grande A.M., Robinson J.K., Previti M.L., Vasek M., Davis J., Van Nostrand W.E. Early-onset subicular microvascular amyloid and neuroinflammation correlate with behavioral deficits in vasculotropic mutant amyloid beta-protein precursor transgenic mice. Neuroscience 2007, 146(1):98-107.
294. Yerabham A.S., Weiergräber O.H., Bradshaw N.J., Korth C. Revisiting disrupted-in-schizophrenia 1 as a scaffold protein. Biol. Chem. 2013, 394:1425-1437.
295. Yohrling G.J., Farrell L.A., Hollenberg A.N., Cha J.H. Mutant huntingtin increases nuclear corepressor function and enhances ligand-dependent nuclear hormone receptor activation. Mol. Cell. Neurosci. 2003, 23:28-38.
296. Yingling J., Youn Y.H., Darling D., Toyo-Oka K., Pramparo T., Hirotsune S., Wynshaw-Boris A. Neuroepithelial stem cell proliferation requires LIS1 for precise spindle orientation and symmetric division. Cell 2008, 132:474-486.
297. Young-Pearse T.L., Suth S., Luth E.S., Sawa A., Selkoe D.J. Biochemical and functional interaction of disrupted-in-schizophrenia 1 and amyloid precursor protein regulates neuronal migration during mammalian cortical development. J. Neurosci. 2010, 30:10431-10440.
298. Zhang H.T., Huang Y., Jin S.L., Frith S.A., Suvarna N., Conti M., O'Donnell J.M. Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme. Neuropsychopharmacology 2002, 27:587-595.
299. Zhang H.T., Zhao Y., Huang Y., Deng C., Hopper A.T., De Vivo M., Rose G.M., O'Donnell J.M. Antidepressant-like effects of PDE4 inhibitors mediated by the high-affinity rolipram binding state (HARBS) of the phosphodiesterase-4 enzyme (PDE4) in rats. Psychopharmacology (Berl.) 2006, 186:209-217.
300. Zhang H.T., Huang Y., Masood A., Stolinski L.R., Li Y., Zhang L., Dlaboga D., Jin S.L., Conti M., O'Donnell J.M. Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B). Neuropsychopharmacology 2008, 33:1611-1623.
301. Zhang H.T. Cyclic AMP-specific phosphodiesterase-4 as a target for the development of antidepressant drugs. Curr. Pharm. Des. 2009, 15:1688-1698.